Press Room
Learn About The Judy Nicholson Foundation
04/03/2013
for The Judy Nicholson Foundation, a charitable foundation established January 2009 after the wife of its founder, Judy Nicholson, passed away after a battle with RCC. The Foundation seeks to raise funds in partnership with researchers at the Mayo Clinic Florida in Jacksonville in an effort to find a method for early detection of kidney cancer and improved treatment. We also seek to increase awareness of this devastating disease through events and promotions and through a strong support group in the Jacksonville area. The Judy Nicholson Foundation is a 501(c)3 charity, has no paid employees and 95% of donations are applied to research grants.
New Market Study Published: Renal Cell Carcinoma - Pipeline Review
04/01/2013
Global Markets Direct's, 'Renal Cell Carcinoma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline.
Survivor Spotlight: Karen Carlier
04/01/2013
Everyone goes through a time of panic and fear. Get past that and be optimistic!
Official Proclamation: Kidney Cancer Awareness Month
03/31/2013
Illinois has proclaimed March, 2013, as Kidney Cancer Awareness Month.
March 2013 Kidney Cancer Association Newsletter
03/31/2013
Save the date for our biggest survivor-patient meeting of the year! Join us on Saturday, April 4 for the 2013 Kidney Cancer Association Patient and Survivor Conference in Houston, TX.
Wear Orange for Kidney Cancer Awareness in March
03/30/2013
March, 2013, is Kidney Cancer Awareness Month--wear ORANGE every day to create awareness of the need for a cure.
Vasohibin-1 is a new predictor of disease-free survival
03/30/2013
Vasohibin-1 (VASH1) is an endothelium-produced angiogenesis inhibitor. Renal cell carcinoma is highly vascularised, but the significance of endogenous VASH1 in renal cell carcinoma has not been defined.
Is this what's in store for kidney cancer patients under Obamacare?
03/29/2013
Once again, NICE regulators toss kidney cancer sufferers into medicine's "dust bin."
Cancer Drug Kills Every Kind of Tumor: Study
03/29/2013
Stanford University scientists have discovered a single drug that has killed or shrunk every kind of cancer tumor it has been used against — a new anti-cancer weapon that some have described as a kind of medical Holy Grail.
Pfizer gets new rebuff from UK cost body for cancer drug
03/28/2013
Pfizer suffered a second rejection in two days from Britain's health cost watchdog NICE as its new kidney cancer drug Inlyta was turned down for use on the state health service.
News Feed| Powered by NeonCRM |